CG-103065

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCG-103065
Drug Alias NameSyk inhibitor (CG Pharmaceuticals)Syk inhibitors (CG Pharmaceuticals)Syk inhibitors (CrystalGenomics)CG-103065
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSpleen tyrosine kinase inhibitors
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsArthritis, RheumatoidNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCG Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCG Pharmaceuticals IncCarna Biosciences Inc
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A